DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Falanga A, Marchetti M, Massi D. et al.
Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitors.
J Am Acad Dermatol 2016;
74 (06) 1254-1256.e4
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.